Enliven Therapeutics Inc - US
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Enliven Therapeutics Inc - US Equity, CUSIP 29337E110.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Enliven Therapeutics Inc - US Equity, CUSIP 29337E110.